Home > Search Clinical Trials > Psychiatry - General Adult/Mental Health (Depression, Anxiety, Etc.)
Clinical Trials: Psychiatry - General Adult/Mental Health (Depression, Anxiety, Etc.)
IRB No. 16-055-2 (Dr. David Steffens, PI): Department of Psychiatry: Adult Repository
The purpose of the repository is to prospectively collect biological samples along with clinical data to facilitate future research studies and pilot analysis related to medical and behavioral health research.
IRB No. U20-082-2 (Dr. Jayesh Kamath, PI): A Phase 3, Multicenter, Randomized, Double-blind Trial of Brexpiprazole as Combination Therapy with Sertraline in the Treatment of Adults with Post-traumatic Stress Disorder. Protocol No. 331-201-00071
This clinical research trial will study adults who have experienced or witnessed a traumatic event within the past 9 years and have unwanted symptoms as a consequence of that traumatic event. An investigational drug is being studied with another medication for the treatment of post-traumatic stress disorder (PTSD). Total participation is approximately 4 months. This includes a screening phase, a double-blind treatment phase, and a follow-up phase. All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided.
IRB No. O21-071-2 (Dr. Jayesh Kamath, PI): A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants with Treatment-resistant Depression (ESKTRD4005)
This is a clinical research study of an investigational medication for adults with treatment-resistant depression (TRD). The purpose of this study is to evaluate the effectiveness, safety, and tolerability of the investigational medication when it is used alone in adults with TRD. Study participation will last up to 24 weeks and includes a screening phase, a double-blind phase, an open-label/observation phase, and a follow-up phase. Qualified participants may receive investigational study medication and some study-required medical care at no cost.